Altogether, our data obtained from Western blot analysis of CML cell lines and primary CML samples, as well as the analysis of a publicly available gene expression dataset demonstrated over-expression of PRL-3 in CML. This evidence concerns the gene PTP4A3 and chronic myelogenous leukemia, BCR-ABL1 positive.